MGMT and glioblastoma: STAT3 inhibition enhanced the efficacy of TMZ by downregulating MGMT gene expression in TMZ-resistant GBM cell lines, while GBM with knockdown of STAT3 gene also exhibited enhanced sensitivity to temozolomide (Han et al., 2016).